Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,210 | 19,330 | 26,120 | 33,480 | 44,540 |
| Marketable Securities | 1,980 | 1,970 | 1,970 | 1,950 | 1,960 |
| Receivables | 70 | 40 | 90 | 80 | 50 |
| Other current assets | 280 | 340 | 600 | 700 | 340 |
| TOTAL | $43,540 | $21,680 | $28,780 | $36,210 | $46,890 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $43,940 | $22,090 | $29,210 | $36,640 | $47,280 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,580 | 7,290 | 6,740 | 5,250 | 6,060 |
| TOTAL | $5,580 | $7,290 | $6,740 | $5,250 | $6,060 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,580 | $7,290 | $6,740 | $5,250 | $6,060 |
| Shareholders' Equity | |||||
| Common Shares | 226,810 | 198,270 | 198,940 | 196,080 | 197,010 |
| Retained earnings | -212,830 | -207,930 | -200,210 | -188,290 | -179,570 |
| Other shareholders' equity | 350 | 310 | 2,950 | 2,970 | 2,870 |
| TOTAL | $38,360 | $14,790 | $22,470 | $31,380 | $41,220 |
| Total Liabilities And Equity | $43,940 | $22,080 | $29,210 | $36,630 | $47,280 |